Biochemical mechanisms of resistance to antimetabolites
- PMID: 348081
- DOI: 10.1159/000401486
Biochemical mechanisms of resistance to antimetabolites
Similar articles
-
Resistance mechanisms to methotrexate in tumors.Stem Cells. 1996 Jan;14(1):5-9. doi: 10.1002/stem.140005. Stem Cells. 1996. PMID: 8820944 Review.
-
The clinical pharmacology of antineoplastic agents (first of two parts).N Engl J Med. 1975 May 22;292(21):1107-13. doi: 10.1056/NEJM197505222922107. N Engl J Med. 1975. PMID: 124015 Review. No abstract available.
-
The molecular perspective: methotrexate.Stem Cells. 1999;17(5):314-5. doi: 10.1002/stem.170314. Stem Cells. 1999. PMID: 10527466 Review. No abstract available.
-
Impairments in antifolate transport are common in retinoblastoma tumor samples.Pediatr Blood Cancer. 2008 Mar;50(3):573-6. doi: 10.1002/pbc.21266. Pediatr Blood Cancer. 2008. PMID: 17554792
-
Methods and mechanisms for the development of MTX resistance in human lymphoid cells.Int J Cancer. 1983 Jan 15;31(1):45-50. doi: 10.1002/ijc.2910310108. Int J Cancer. 1983. PMID: 6832848 No abstract available.
Cited by
-
Mathematical modeling of folate metabolism.Wiley Interdiscip Rev Syst Biol Med. 2013 Sep-Oct;5(5):603-13. doi: 10.1002/wsbm.1227. Epub 2013 May 22. Wiley Interdiscip Rev Syst Biol Med. 2013. PMID: 23703958 Free PMC article.
-
Decreased host toxicity in vivo during chronic treatment with 5-flourouracil.Cancer Chemother Pharmacol. 1985;14(1):63-9. doi: 10.1007/BF00552728. Cancer Chemother Pharmacol. 1985. PMID: 3965161
-
Cytogenetical changes during early stages of development of methotrexate resistance in HeLa cells.Med Oncol Tumor Pharmacother. 1985;2(1):33-8. doi: 10.1007/BF02934778. Med Oncol Tumor Pharmacother. 1985. PMID: 4058076